KITE INNOVATION (EUROPE) LIMITED

Their core work

Kite Innovation is a UK-based SME that provides innovation management, dissemination, and communication services to EU research consortia. The extremely diverse range of project topics — from quantum cascade lasers to Alzheimer's disease to aortic aneurysm repair — combined with consistently modest funding shares (averaging EUR 45,000) points clearly to a cross-cutting support role rather than technical research. They help consortia communicate results, manage exploitation strategies, and maximize the impact and visibility of research outputs across health, digital, and manufacturing sectors.

What they specialise in

How they've shifted over time

Kite Innovation's early H2020 work (2015-2016) was spread broadly across security sensing (CHEQUERS), laser processing (HIPERDIAS, TresClean), and digital health (EmERGE), establishing them as a versatile dissemination partner. Their later projects leaned more heavily into clinical and health research communication, including Alzheimer's trials (MOPEAD, ADAPTED) and surgical innovation (PAPA-ARTIS). This shift suggests growing specialization in communicating complex health and clinical trial outcomes to diverse audiences.

Kite appears to be concentrating its dissemination expertise increasingly on health and clinical research projects, making them a strong candidate for future health-sector consortia needing communication partners.

How they like to work

Kite Innovation operates exclusively as a consortium participant, never as coordinator, which is typical for specialized service providers embedded in larger research teams. With 104 unique partners across 19 countries from just 9 projects, they work in large, diverse consortia and rarely repeat partnerships — indicating they are sought after by many different research groups rather than tied to a few recurring collaborators. This broad network makes them easy to integrate into new consortia without overlap concerns.

Exceptionally broad network of 104 unique partners across 19 countries from only 9 projects, averaging over 11 consortium partners per project. Their reach spans Western and Southern Europe extensively, with strong connections to both academic institutions and industry players.

What sets them apart

Kite Innovation's value lies in their ability to handle dissemination and communication across technically diverse domains — few SMEs can credibly manage outreach for both quantum laser sensors and Alzheimer's clinical trials. Their Huddersfield base gives them access to the UK's strong university and innovation ecosystem, while their 19-country network demonstrates genuine pan-European reach. For consortium builders, they offer a proven, low-risk dissemination partner with a track record of integrating smoothly into large, multi-sector consortia.

Highlights from their portfolio

• EmERGE
  Largest funding share (EUR 118,601) and focused on HIV mHealth patient empowerment — their most substantial and socially impactful engagement.
• PAPA-ARTIS
  Longest-running project (2017-2024) involving a randomized controlled trial for paraplegia prevention in aortic surgery, demonstrating commitment to complex clinical communication.
• CHEQUERS
  Security-focused project on explosives detection using quantum cascade lasers — shows their ability to work in sensitive, security-adjacent domains.